EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Assessment of Bacteriological Profile and Outcome of Empyema Thoracis of Hospitalized Children

Sweta Sadani, Mrinalini Das

Pediatric Respirology and Critical Care Medicine · 2022

DOI: 10.4103/prcm.prcm_12_22 ↗
AbstractBibliografische Angaben

Abstract

Background: Empyema is often associated with the consequence of infection including pneumonia, tuberculosis, or lung abscess. This study was conducted to assess the clinico-etiological profile and outcomes of empyema thoracis cases. Materials and Methods: This was a prospective hospital-based observational study conducted from July 2019 to June 2020 which included patients of either sex, aged between 2 months to ≤12 years, with empyema thoracis confirmed by radiological evidence of pleural fluid. Clinico-etiological details were collected and presented using appropriate statistics. Results: A total of 42 patients were included in the study, of which 35.7% were aged between 4 and 7.99 years and 27 patients (64.3%) were male. Twenty (47.6%) patients had a history of cough for 7–14 days while eight had cough for >14 days; however, a total of 29 (87.9%) patients had breathing difficulty for ≤7 days. Chest pain was observed in 16.7% of patients. Chest X-ray showed that right side pleural effusion was more commonly affected than the left pleural effusion (69.0% vs. 31.0%). The most common micro-organism pleural fluid culture was Staphylococcus aureus ( n = 8; 20.5%). The majority of patients with empyema thoracis had elevated levels of leukocytes (>11,000 cumm) and CRP levels (>10 mg/dL) [92.9% and 97.6%, respectively]. Conclusion: The present study showed that most of the children presented at the age of 4–7.99 years with a male predominance. S. aureus was the major organism associated with pediatric empyema in this region.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →